Documents › 3a0160e9792366039c4c24908c2d7e1cb47c0353:1-73

NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users

POST board policyreference 2022-12 73 pages (file pages 1–73) original file
About this document
Layer
attachment: a document a meeting packet links to
Type as titled
publication (kind from doc_type)
File
3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
Cases
POST 2313715 · Jaime Bermudez (filed under case)

About: Jaime Bermudez (case)

Page 25 · file page 25 larger image
Image of page 25; its text is alongside
Text: OCR

Crash Information

When hospital research staff were allowed to be in patient care areas, they were able to listen to EMS reports being provided to the treating staff and record details of the crash on the data collection cards. This information was supplemented by reviews of EMS run sheets and hospital records that contained details on the crash. The study also reviewed crash reports when available to verify crash details. When access to patient care areas was restricted during the public health emergency, the study relied more heavily on EMS run sheets, hospital records, and crash reports to gather crash details. No personal identifiers were ever entered into the study database.

Selected Drugs

NHTSA research traditionally focuses on testing for those drugs that are known, or suspected, to impair cognitive and motor skills important for driving safety. These include alcohol as well as OTC, prescription, and illegal drugs. The results of the prior NRSs, the Washington roadside survey, and Virginia Beach study formed the foundation for the drugs selected for analysis in the present study. Table 6 contains the list of the parent drugs and metabolites included in this study's toxicological testing.

Table 6. Selected Drugs and Metabolites for Toxicology Testing

Class/Category Parent Drug or Metabolite (Abbreviation)
Alcohol ethyl alcohol
Cannabinoids delta-9-tetrahydrocannabinol (<math>\Delta</math>-9-THC), 11-hydroxy-<math>\Delta</math>9-tetrahydrocannabinol (11-OH-THC), 11-nor-9-carboxy-<math>\Delta</math>9-tetrahydrocannabinol (11-COOH-THC)#
Stimulants cocaine, benzoylecgonine (BZE)#, cocaethylene; amphetamine; methamphetamine; 3,4-methylenedioxy-methamphetamine (MDMA); 3,4-methylenedioxyamphetamine (MDA); ephedrine; pseudoephedrine; phenylpropanolamine; phentermine; methylphenidate
Sedatives
Benzodiazepines
Barbiturates
Muscle Relaxers
Sleep Aids
diazepam; nordiazepam*; oxazepam*; temazepam*; clonazepam, 7-aminoclonazepam; alprazolam; lorazepam; chlordiazepoxide; midazolam; bromazepam; butalbital; secobarbital; phenobarbital; carisoprodol; meprobamate; cyclobenzaprine; zolpidem
Opioids 6-monoacetylmorphine (6-AM)^; morphine*; codeine; hydrocodone; hydromorphone*; oxycodone; oxymorphone*; methadone, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP)#; buprenorphine norbuprenorphine; fentanyl, norfentanyl#; furanylfentanyl; acetylfentanyl; carfentanil; fluorofentanyl; tramadol
Antidepressants sertraline; fluoxetine; amitriptyline; nortriptyline; imipramine; desipramine; citalopram; doxepin; venlafaxine; trazadone
Over the Counter dextromethorphan; diphenhydramine; chlorpheniramine; doxylamine
Other phencyclidine; ketamine; <math>\alpha</math>-pyrrolidinopentiophenone (alpha-PVP)

Inactive metabolite.

*These compounds can be parent drugs or active metabolites of other drugs.

^Heroin can only be definitively detected by the presence of the 6-AM metabolite.

17

Keys: ← → or j k turn pages; / finds.